Similar Articles
111 Viral hepatitis prevalence in patients with active and latent tuberculosis
112 Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications
113 Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a “special population”?
114 Liver transplantation for hepatitis B virus: Decreasing indication and changing trends
115 Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
116 Predictive factors associated with hepatitis C antiviral therapy response
117 3.0T 1H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C
118 Hepatitis C: New challenges in liver transplantation
119 Autoantibodies in chronic hepatitis C: A clinical perspective
120 Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA